VIVO Share Price

Open 16.75 Change Price %
High 16.85 1 Day 0.00 0.00
Low 16.60 1 Week -0.35 -2.05
Close 16.75 1 Month -1.15 -6.42
Volume 206043 1 Year -1.87 -10.04
52 Week High 21.49
52 Week Low 15.75
VIVO Important Levels
Resistance 2 16.98
Resistance 1 16.89
Pivot 16.73
Support 1 16.61
Support 2 16.52
NASDAQ USA Most Active Stocks
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
DRYS 1.01 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
More..
NASDAQ USA Top Gainers Stocks
CPSL 0.10 66.67%
LOCM 0.09 50.00%
GLBS 9.70 31.79%
LTRE 2.85 29.55%
ETRM 7.96 29.22%
INFI 2.00 29.03%
QKLS 0.14 27.27%
PRKR 2.57 26.60%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
More..
NASDAQ USA Top Losers Stocks
HEAT 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Meridian Bioscience Inc. (NASDAQ: VIVO)

VIVO Technical Analysis 4
As on 20th Jan 2017 VIVO Share Price closed @ 16.75 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 19.03 & Sell for SHORT-TERM with Stoploss of 17.31 we also expect STOCK to react on Following IMPORTANT LEVELS.
VIVO Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
VIVO Other Details
Segment EQ
Market Capital 814715968.00
Sector Healthcare
Industry Diagnostic Substances
Offical website http://www.meridianbioscience.com
VIVO Address
VIVO
3471 River Hills Drive
Cincinnati, OH 45244
United States
Phone: 513-271-3700
Fax: 513-271-3762
Interactive Technical Analysis Chart Meridian Bioscience Inc. ( VIVO NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Meridian Bioscience Inc.
VIVO Business Profile
Meridian Bioscience, Inc. (Meridian) is an integrated life science company. The Company is engaged in developing, manufacturing, selling and distribution of clinical diagnostic test kits, for certain gastrointestinal, viral, respiratory and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/ quantitative polymerase chain reaction (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals under cyclic guanosine monophosphate (cGMP) conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. The Company operates in three segments: U.S. Diagnostics, European Diagnostics and Life Science.